Truscreen Group Limited (NZX and ASX:TRU) (TruScreen or Company) is pleased to announce the appointment of Dr. Dexter Cheung as a non-executive director of TruScreen.Dr. Cheung is an experienced medical device engineer and specialist in product research and development, with more than 20 years' experience. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company and a global leader in respiratory medical devices.
Dr Cheung's technical background in opto-electronics and expertise in medical device engineering is highly relevant to TruScreen whose cervical cancer screening device harnesses optical and electrical signatures for screening results.
Dr Cheung brings a strong understanding of manufacturing processes and has travelled extensively to China, USA, Europe, United Kingdom and Japan working closely with medical device manufacturers and component suppliers in these regions.
Dr Cheung has published eight papers and has eight international patents pending or granted jointly with collaborators or in his name, focusing on respiratory air flow management. He has previously served on a visiting committee of the Auckland University of Technology.
Dr. Cheung holds a first-class honours degree in Bachelor of Technology, a Master of Engineering (first class honours) degree and a Doctor of Philosophy (in physics) from his alma mater, University of Auckland.
Mr. Chris Lawrence has also announced his retirement from the board due to health reasons. Shareholders would recall that Mr. Lawrence was unable to attend the last annual shareholders general meeting in August 2020 for health reasons.
Tony Ho, Chairman commented'On behalf of the board, I thank Chris Lawrence for his unstinting contributions to the board over the past four years.
'The directors are pleased to welcome Dr. Dexter Cheung to the Board of TruScreen. He brings very relevant technical and product development experience with a major global healthcare firm, along with the business experience and manufacturing expertise within our key markets of China and Central America. This skill set will assist TruScreen as we continue to evolve and scale up.'
TruScreen Limited published this content on 02 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 March 2021 02:52:08 UTC.